Skip to main content
Premium Trial:

Request an Annual Quote

Agencourt Awards Grant to Dana Farber Cancer Institute Researcher

NEW YORK, Feb. 9 (GenomeWeb News) - Agencourt Bioscience said today that it has awarded the $10,000 Agencourt Pan-Mass Genomic Services Grant to Dana-Farber Cancer Institute researcher Patricia Dahia.

 

Dahia, an instructor of medicine at the cancer center, received the grant for her proposal entitled "A Novel Familial Pheochromocytoma Susceptibility Locus: Toward Identification of the Target Gene." The goal of the project, said Agencourt, is to identify the gene or genes responsible for novel familial pheochromocytoma syndrome, a rare tumor of the adrenal gland that increases adrenaline production and dangerously elevates blood pressure.

 

The company noted that its high-throughput sequencing technologies will be used by Dahia to identify the susceptibility gene or genes in the disorder.

 

 

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.